Hana Pharm Co Ltd Cash Flow-to-Debt Ratio
Hana Pharm Co Ltd cash flow-to-debt ratio. Hana Pharm Co Ltd (293480) has a Cash Flow-to-Debt Ratio of 0.06x as of June 2026, meaning its operating cash flow of ₩6.91 Billion could theoretically repay 0% of its total liabilities (₩114.94 Billion) in one year. Check Hana Pharm Co Ltd (293480) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Hana Pharm Co Ltd (2016–2025)
Cash flow-to-debt ratio of Hana Pharm Co Ltd from 2016 to 2025. Historical debt coverage capacity for Hana Pharm Co Ltd across 10 annual periods. Check 293480 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Hana Pharm Co Ltd Cash Flow-to-Debt Ratio by Year (2016–2025)
Hana Pharm Co Ltd cash flow-to-debt ratio by year from 2016 to 2025. Year-by-year debt coverage analysis for Hana Pharm Co Ltd. For the full cash flow conversion analysis, see Hana Pharm Co Ltd operating cash flow efficiency.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.09x | ₩9.18 Billion | ₩104.73 Billion | ▼ -74.8% |
| 2024 | 0.35x | ₩25.30 Billion | ₩72.83 Billion | ▲ +32.9% |
| 2023 | 0.26x | ₩18.40 Billion | ₩70.40 Billion | ▼ -34.3% |
| 2022 | 0.40x | ₩30.88 Billion | ₩77.57 Billion | ▼ -19.9% |
| 2021 | 0.50x | ₩25.66 Billion | ₩51.60 Billion | ▲ +41.1% |
| 2020 | 0.35x | ₩15.58 Billion | ₩44.20 Billion | ▼ -52.5% |
| 2019 | 0.74x | ₩31.72 Billion | ₩42.70 Billion | ▼ -0.4% |
| 2018 | 0.75x | ₩27.59 Billion | ₩36.99 Billion | ▲ +77.0% |
| 2017 | 0.42x | ₩25.38 Billion | ₩60.25 Billion | ▲ +99.8% |
| 2016 | 0.21x | ₩12.46 Billion | ₩59.11 Billion | — |